Cancer

Expert endorses genetic testing for BRCA1 and BRCA2

Professor Kelly Metcalfe, of U of T's Lawrence S. Bloomberg Faculty of Nursing, is leading the charge against hereditary breast and ovarian cancers by helping establish the standard protocol for addressing cancers associated ...

Apr 18, 2017
popularity0 comments 0

Promising new drug development could treat cachexia

According to the National Cancer Institute, nearly one-third of cancer deaths can be attributed to a wasting syndrome known as cachexia. Cachexia, an indicator of the advanced stages of disease, is a debilitating disorder ...

Apr 18, 2017
popularity1 comments 0

Research leads to new drug for hard-to-treat lymphomas

Japan has become the first country to approve a lymphoma drug developed through research at Albert Einstein College of Medicine. This also marks the first time that an Einstein-licensed drug has been approved for patient ...

Apr 17, 2017
popularity5 comments 0